“Systemic Effects of GLP-1 and Dual GIP/GLP-1 Receptor Agonism in Obesity, Cardiovascular Health, and Neurodegeneration: Review Article” (2025) Journal of Pharma Insights and Research, 3(6), pp. 018–024. doi:10.69613/akgbn956.